Please try another search
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Benjamin Klein | 50 | 2022 | COO & Director |
Elias Vamvakas | 65 | 2018 | Independent Director |
Frank Tworecke | 77 | 2018 | Independent Director |
Brian Paul Burke | 67 | 2018 | Independent Director |
Juliana Elstad | 47 | 2024 | Independent Director |
Colleen R. Campbell | 65 | 2018 | Lead Independent Director |
Sasha Cucuz | 45 | 2018 | Executive Chairman |
William P. Leonard | 59 | 2011 | President, CEO & Director |
Surindra Kaur Mann | 57 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review